Overview and Clinical Importance
Avian Ganglioneuritis (AG), also known as Proventricular Dilatation Disease (PDD) or Avian Bornaviral Ganglioneuritis (ABG), is a chronic, progressive, and often fatal neurological disease affecting primarily psittacine birds (parrots). First recognized in the 1970s as "Macaw Wasting Disease," the causative agent, Avian Bornavirus (ABV), was not identified until 2008. This disease represents one of the most significant infectious neurological conditions in avian medicine and is a high-yield topic for veterinary board examinations.
The disease is characterized by lymphoplasmacytic infiltration of the ganglia and nerves, particularly affecting the myenteric plexus of the gastrointestinal tract, the central nervous system, and peripheral nerves. Clinical manifestations vary widely, ranging from primarily gastrointestinal signs to predominantly neurological presentations, or a combination of both.
Etiology
Causative Agent: Avian Bornavirus
Avian Bornavirus (ABV) is an enveloped, non-segmented, negative-sense, single-stranded RNA virus belonging to the family Bornaviridae within the order Mononegavirales. Unlike other members of this order that replicate in the cytoplasm, bornaviruses employ intranuclear transcription and replication, which contributes to viral persistence and immune evasion.
Virus Characteristics
Epidemiology
Species Affected
Avian Ganglioneuritis has been reported in more than 80 avian species, with psittacine birds being most commonly affected. The disease has worldwide distribution in captive bird populations.
Transmission
The exact mode of transmission remains incompletely understood, but evidence supports multiple routes:
- Fecal-oral transmission: Most commonly implicated route; virus shed intermittently in feces and urates
- Aerosol/respiratory: Virus present in nasal secretions and respiratory droplets
- Vertical transmission: ABV RNA has been detected in eggs from infected hens
- Feather/dander: Viral RNA detected in feather calami
- Direct contact: Close contact between birds, especially during breeding
Prevalence
Studies estimate that 10-45% of captive psittacines may be infected with ABV, with some estimates suggesting at least one in three healthy captive parrots tests positive. Importantly, NOT all ABV-positive birds develop clinical disease. Many birds remain asymptomatic carriers for extended periods or their entire lives.
Pathogenesis
The pathogenesis of ABV-induced ganglioneuritis involves a complex interaction between the virus and the host immune response. The disease is characterized as a non-cytolytic, immune-mediated process rather than direct viral cytopathic effects.
Disease Development
- Viral Entry and Dissemination: ABV enters through mucosal surfaces (oral, respiratory) and spreads to neural tissues
- Persistent Infection: Virus establishes persistent infection in neurons and glial cells without causing direct cell death
- Immune Response: Host T-cell mediated immune response targets infected neurons, causing lymphoplasmacytic infiltration
- Neural Damage: Progressive inflammation leads to neuronal dysfunction and loss
- Functional Impairment: Damage to autonomic ganglia causes GI dysmotility; CNS involvement causes neurological signs
Exam Focus: The pathology of ABV infection is described as "non-suppurative, lymphoplasmacytic ganglioneuritis" - this terminology is frequently tested! The infiltrating cells are primarily CD3-positive T lymphocytes, macrophages/microglia, and PAX5-positive B lymphocytes.
Tissue Distribution of Lesions
Clinical Presentation
Clinical signs are highly variable and depend on which organ systems are most severely affected. The incubation period is prolonged and variable, estimated at 2-4 weeks to months or even years. Disease progression can be slow and insidious or relatively rapid.
Clinical Signs by System
Diagnosis
Diagnosis of ABV infection and clinical PDD/AG requires a multimodal approach. No single test is definitive ante-mortem, and a combination of clinical signs, imaging, and laboratory testing is recommended.
Diagnostic Methods
Radiographic Findings
Survey and contrast radiography are valuable diagnostic tools:
- Proventricular dilatation: Moderately to markedly distended proventriculus containing ingesta and variable gas
- Proventriculus extending beyond liver margin: On VD view, proventriculus extends beyond hepatic silhouette
- Thin proventricular wall: Wall appears thin and often transparent at necropsy
- Delayed GI transit time: Barium should reach cloaca within 3 hours in healthy birds; delayed in PDD
- Ventricular displacement: Ventriculus may be displaced to the right and cranially by dilated proventriculus
Recommended Diagnostic Protocol
- Complete physical examination
- CBC and biochemistry panel (may show hypoalbuminemia, elevated amylase/lipase)
- Fecal examination (rule out parasites, Macrorhabdus ornithogaster)
- Survey radiographs (assess proventricular size)
- Contrast study with barium if indicated
- ABV RT-PCR on combined choanal/cloacal swab AND/OR feather calami
- ABV serology (anti-N protein antibodies)
- Crop biopsy if other tests inconclusive and clinical suspicion high
Differential Diagnosis
Other conditions causing similar clinical signs or radiographic findings:
- Heavy metal toxicosis (especially lead and zinc) - can cause GI stasis and neurological signs
- Macrorhabdus ornithogaster (megabacteria/avian gastric yeast) - causes GI signs
- Foreign body obstruction - mechanical obstruction of GI tract
- GI neoplasia (papillomas, adenocarcinoma)
- Bacterial/fungal infections - ingluvitis, proventriculitis
- Psittacine herpesvirus - can cause GI and CNS signs
- Paramyxovirus - neurological signs
Treatment and Management
IMPORTANT: There is currently NO CURE for ABV infection or PDD. Treatment is palliative and supportive. A positive ABV test is NOT a death sentence - many birds live for years with appropriate management. The goal is to minimize clinical signs and maintain quality of life.
Therapeutic Options
Exam Focus: Recent controlled studies have shown that NEITHER celecoxib NOR meloxicam significantly altered clinical progression, viral shedding, or histopathologic lesions in experimentally infected cockatiels. Furthermore, NSAID treatment may cause GI toxicity (bleeding) in affected birds. The current evidence does NOT support routine NSAID use for PDD treatment. Board questions may test this updated understanding!
Prognosis
- Birds with primarily GI signs: Guarded to poor; may survive months to years with supportive care
- Birds with neurological signs: Poor; neurological form typically progresses more rapidly
- Asymptomatic ABV-positive birds: Variable; many never develop clinical disease
- Overall: Once clinical signs develop, the disease is typically progressive and eventually fatal
Prevention and Control
Biosecurity Measures
- Quarantine new birds for minimum 60-90 days with repeated testing
- Test all new acquisitions with both PCR and serology
- Separate ABV-positive birds from negative birds
- Do not share cages, food dishes, toys, or perches between positive and negative birds
- Work with ABV-negative birds BEFORE handling positive birds
- Change clothing or shower between handling positive and negative birds
- Standard disinfection protocols effective (quaternary ammonium, dilute bleach)
Memory Aid - "ABV STOPS": Asymptomatic carriers common, Bornavirus causes immune-mediated damage, Virus is labile (easy to disinfect), Seeds undigested = classic sign, Transmission fecal-oral primarily, Only supportive treatment, PCR and serology together for best diagnosis, Separate positive from negative birds